The most up-to-date news on all aspects of health, medicine, and well-being. This section contains releases regarding new medical technology, studies, and publications, as well as information on health education programs and campaigns. Also included are stories about health insurance, the care industry, and awards won by top ranking doctors, surgeons, and other healthcare providers. Learn about new developments regarding treatments and medications, and follow the latest economic and legal news in the medical world.
NEMLUVIO is the first authorized monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31.1 IL-31 is a neuroimmune cytokine that drives itch and is...
RYBELSUS® (semaglutide tablets) is the first glucagon-like peptide-1 (GLP-1) approved in Canada to reduce the risk of major adverse cardiovascular events (MACE).1 RYBELSUS® (semaglutide tablets) is...
mylife Loop powered by mylife CamAPS FX becomes the first automated insulin delivery system in Canada compatible with two glucose monitoring systems for people living with type 1 diabetes MONTRÉAL,...
TORONTO, Jan. 14, 2026 /CNW/ - Eli Lilly Canada Inc. ("Lilly") announced today that Ontario leads the way as the first province to add Olumiant® for severe alopecia areata to its public drug...
Nasopharyngeal Carcinoma is a rare and debilitating disease with limited effective treatment options currently available to Canadian patients Approval supported by results of the RATIONALE-309 study...
Prevalence of Autism Spectrum Disorder (ASD) among children and youth aged 1 to 17 years, is about 2% (1 in 50) and is equivalent to about 150,000 cases in Canada in 2025 [1, 2]. Smith-Magenis...
Our free and easy-to-use journalist tools can help you stay on top of the best story ideas for your beat.
GET STARTED NOW
Reach the media, customers, and investors and achieve your communications goals by leveraging Cision’s multichannel content distribution network and targeting tools.
LEARN MORE
